Irrespective of the mechanism behind the reduced ATP production (or increased ATP consumption), an increase in G6PD activity has been related to increased lipid dysfunction and insulin resistance [20], thus landing support to our observation and its experimental and clinical relevance. The gene discussed is G6PD; the disease is Insulin resistance.